Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-24-000903
Filing Date
2024-02-22
Accepted
2024-02-22 06:06:04
Documents
22
Period of Report
2024-02-21

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_022124.htm 6-K 87078
2 GRAPHIC logo.jpg GRAPHIC 7781
3 GRAPHIC ca.jpg GRAPHIC 24896
4 GRAPHIC agm2024_01.jpg GRAPHIC 245765
5 GRAPHIC agm2024_02.jpg GRAPHIC 173591
6 GRAPHIC agm2024_03.jpg GRAPHIC 179773
7 GRAPHIC agm2024_04.jpg GRAPHIC 380171
8 GRAPHIC agm2024_05.jpg GRAPHIC 363366
9 GRAPHIC agm2024_06.jpg GRAPHIC 413997
10 GRAPHIC agm2024_07.jpg GRAPHIC 402529
11 GRAPHIC agm2024_08.jpg GRAPHIC 289615
12 GRAPHIC agm2024_09.jpg GRAPHIC 327307
13 GRAPHIC agm2024_10.jpg GRAPHIC 348066
14 GRAPHIC agm2024_11.jpg GRAPHIC 235795
15 GRAPHIC agm2024_12.jpg GRAPHIC 260514
16 GRAPHIC agm2024_13.jpg GRAPHIC 206059
17 GRAPHIC agm2024_14.jpg GRAPHIC 187273
18 GRAPHIC agm2024_15.jpg GRAPHIC 195943
19 GRAPHIC agm2024_16.jpg GRAPHIC 195196
20 GRAPHIC agm2024_17.jpg GRAPHIC 165827
21 GRAPHIC agm2024_18.jpg GRAPHIC 114779
22 GRAPHIC agm2024_19.jpg GRAPHIC 52595
  Complete submission text file 0001171843-24-000903.txt   6658172
Mailing Address NOVO ALLE DK 2880 BAGSVAERD DENMARK G7 00000
Business Address NOVO ALLE DK 2880 BAGSVAERD DENMARK G7 00000 4544448888
NOVO NORDISK A S (Filer) CIK: 0000353278 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 333-82318 | Film No.: 24662169
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)